Shares of Thyrocare Technologies rose 1.99% to close at Rs 1,269.70 apiece on the NSE. (Photo Source: Envato)

Show Quick Read Summary is AI Generated. Newsroom Reviewed

Docon Technologies, one of the promoters of Thyrocare Technologies, on Friday divested a 10% stake in the diagnostics chain for Rs 667 crore through an open market transaction.

According to the bulk deal data on the National Stock Exchange (NSE), Docon Technologies offloaded a little over 53.32 lakh shares, or 10.06% stake, in the company.

The transaction was valued at around Rs 667.69 crore and was executed at an average price of Rs 1,252.03 apiece.

After the stake sale, Docon Technologies' holding in Thyrocare Technologies has come down to 61% from 71.06%.

Meanwhile, ICICI Prudential Mutual Fund (MF), Aditya Birl

See Full Page